Literature DB >> 15884002

Rho GTPases, dendritic structure, and mental retardation.

Sarah E Newey1, Vanisree Velamoor, Eve-Ellen Govek, Linda Van Aelst.   

Abstract

A consistent feature of neurons in patients with mental retardation is abnormal dendritic structure and/or alterations in dendritic spine morphology. Deficits in the regulation of the dendritic cytoskeleton affect both the structure and function of dendrites and synapses and are believed to underlie mental retardation in some instances. In support of this, there is good evidence that alterations in signaling pathways involving the Rho family of small GTPases, key regulators of the actin and microtubule cytoskeletons, contribute to both syndromic and nonsyndromic mental retardation disorders. Because the Rho GTPases have been shown to play increasingly well-defined roles in determining dendrite and dendritic spine development and morphology, Rho signaling has been suggested to be important for normal cognition. The purpose of this review is to summarize recent data on the Rho GTPases pertaining to dendrite and dendritic spine morphogenesis, as well as to highlight their involvement in mental retardation resulting from a variety of genetic mutations within regulators and effectors of these molecules. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15884002     DOI: 10.1002/neu.20153

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  154 in total

Review 1.  The Biology of Forgetting-A Perspective.

Authors:  Ronald L Davis; Yi Zhong
Journal:  Neuron       Date:  2017-08-02       Impact factor: 17.173

2.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

3.  Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation.

Authors:  Andrew D Powell; Kalbinder K Gill; Pierre-Philippe Saintot; Premysl Jiruska; Jamel Chelly; Pierre Billuart; John G R Jefferys
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 4.  Structural and synaptic plasticity in stress-related disorders.

Authors:  Daniel J Christoffel; Sam A Golden; Scott J Russo
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

5.  Electron tomographic analysis of synaptic ultrastructure.

Authors:  Alain C Burette; Thomas Lesperance; John Crum; Maryann Martone; Niels Volkmann; Mark H Ellisman; Richard J Weinberg
Journal:  J Comp Neurol       Date:  2012-08-15       Impact factor: 3.215

Review 6.  Signaling networks that regulate cell migration.

Authors:  Peter Devreotes; Alan Rick Horwitz
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-08-03       Impact factor: 10.005

Review 7.  Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.

Authors:  Michelle D Amaral; Christopher A Chapleau; Lucas Pozzo-Miller
Journal:  Pharmacol Ther       Date:  2006-11-21       Impact factor: 12.310

8.  Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.

Authors:  Glenn T Konopaske; Darrick T Balu; Kendall T Presti; Grace Chan; Francine M Benes; Joseph T Coyle
Journal:  Schizophr Res       Date:  2018-05-11       Impact factor: 4.939

Review 9.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

10.  Nitric oxide induces pathological synapse loss by a protein kinase G-, Rho kinase-dependent mechanism preceded by myosin light chain phosphorylation.

Authors:  Carmen R Sunico; David González-Forero; Germán Domínguez; José Manuel García-Verdugo; Bernardo Moreno-López
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.